- Global Pharma News & Resources

Disposable Insulin-Delivery Device Market to expand at a 7.7% value CAGR by 2032

The disposable insulin-delivery device market is projected to reach a value of US$ 14,585.6 million in 2022, with a Compound Annual Growth Rate (CAGR) of 7.7% between 2022 and 2032, leading to a total market value of US$ 32,887.5 million. This growth is primarily driven by the increase in diabetes-related health expenditure in emerging nations.

The International Diabetes Federation (IDF) reports that one-tenth of the total population affected by diabetes has Type 1, and 10% of these individuals do not currently use insulin delivery devices, creating significant potential for the expansion of the disposable insulin-delivery device market during the forecast period.

Request Sample@

Pens are currently the most popular choice for insulin delivery devices, holding over 36% of the market share, compared to syringes, pumps, and jet injectors. The design and ease of use of pens have contributed to their high adoption rate. NovoPen is currently leading the market, with a memory function as an added feature.

Home care is the primary end-user of disposable insulin-delivery devices, accounting for over 45% of the market share. The cost-effectiveness of home care compared to hospital care is a major factor in this trend. Additionally, the portability of these devices adds to their convenience for home care use. Future Market Insights has conducted an in-depth analysis of the disposable insulin-delivery device market, including both micro and macro factors, in their latest market study titled ‘Disposable Insulin-Delivery Device Market.’

Key Takeaways from Disposable Insulin-Delivery Device Market

  • North America controls 33% of the market. This could be linked to rising diabetes rates, viable government initiatives, and the presence of multiple disposable insulin delivery device manufacturers. According to the CDC, diabetes affects more than 37 million individuals in the United States.
  • With improvements in healthcare infrastructure in numerous parts of Europe, Europe now holds 29% of the market. In 2019, more than 32 million adults in the EU were diagnosed with diabetes.
  • In the Asia-Pacific region, rising diabetes awareness is one of the important drivers driving the disposable insulin-delivery device market, and this trend is likely to continue.

Request Discount@

Key Players:

  • Animas Corporation
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic Plc.
  • Valeritas, Inc.,
  • Tandem Diabetes Care, Inc.
  • Johnson & Johnson
  • Beta Bionics Inc.
  • Abbott Laboratories
  • Becton Dickinson & Co.
  • EyeSense GmbH

Competitive Landscape

  • Abbott did announce a partnership with Fitterfly, Healthifyme, Zyla Health, 1MG, GOQii, PharmEasy,, and BeatO in February 2022 as a move towards holistic diabetes management treatment. Abbott, through alliances, provides glucose monitoring solutions to nearly 8 million diabetic patients, 6.5 million of whom have access to 1MG and PharmEasy.
  • Insulet Corp. announced in January 2022 that the US FDA had authorised the new Omnipod 5 system, ushering it into the world of AID (automated insulin delivery).
  • Novo Nordisk announced the availability of two smart linked insulin pens called ‘NovoPen Echo Plus’ and ‘NovoPen 6’ in March 2022, which would be accessible on prescription for patients receiving Novo Nordisk insulin in the UK.
  • Sanofi and Roche will collaborate in November 2021 to increase the usage of disposable insulin pens. Local players are also being approached in order to expand market penetration.

“A large chunk of population is contracting diabetes, which asks for disposable insulin-delivery devices”, thereby accelerating the market for the same”, says an analyst from Future Market Insights.

Request Customization@

What does the Report have at its discretion?

  • In its latest analysis, Future Market Insights provides an exclusive perspective and numerous real-time data on the disposable insulin-delivery device market, presenting historical demand assessments from 2016 to 2021 and predictions from 2022 to 2032.
  • The study is divided into three sections: product type (disposable insulin-delivery pumps, disposable insulin-delivery patches, disposable insulin-delivery pens, and disposable insulin-delivery syringes), illness indication (type I and type II diabetes), and distribution channel (hospital pharmacies, retail pharmacies, online sales, and diabetes clinics).
  • With an increase in the number of diabetic patients as a result of obesity, ageing, and sedentary lifestyles, the global disposable insulin-delivery device market is poised to make waves in the healthcare industry in the next years.

Want more insights:

In North America, the market is mature and dominated by established players such as Novo Nordisk and Eli Lilly. The increasing prevalence of diabetes, favorable reimbursement policies, and the availability of advanced insulin delivery technologies have been the key drivers of market growth in this region.

Key Segments Profiled in the Disposable Insulin-Delivery Device Market

Disposable Insulin-Delivery Device Market by Product Type:

  • Disposable Insulin-Delivery Pumps
  • Disposable Insulin-Delivery Patches
  • Disposable Insulin-Delivery Pens
  • Disposable Insulin-Delivery Syringes

Disposable Insulin-Delivery Device Market by Disease Indication:

  • Disposable Insulin-Delivery Devices for Type I Diabetes
  • Disposable Insulin-Delivery Devices for Type II Diabetes

Disposable Insulin-Delivery Device Market by Distribution Channel:

  • Disposable Insulin-Delivery Devices Sales via Hospital Pharmacies
  • Disposable Insulin-Delivery Devices Sales via Retail Pharmacies
  • Disposable Insulin-Delivery Devices Sales via Online Sales
  • Disposable Insulin-Delivery Devices Sales via Diabetes Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
United Arab Emirates
For Sales Enquiries:

Editor Details

Last Updated: 16-Mar-2023